AMIDEX35 Israel Fund Class A (AMDAX)

10.71
Net Asset Value
-0.28%
1 Day
-1.47%
Year-to-Date
Overall Morningstar Rating
Miscellaneous region
Style or Category
5.5
Sales Expenses
4.34%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term growth of capital. The fund will invest at least 95% of its net assets in the common stocks of the companies comprising the AMIDEX35-- Index- in approximately the same percentages as those companies are included in the index or until the fund's net assets reach $25 million- the Adviser may invest fund assets in a representative sample of index securities and other permissible securities. The AMIDEX35-- Index is an unmanaged index consisting of the 35 largest publicly traded Israeli companies- as measured by market capitalization. It is non-diversified.

Performance

1 month-4.29% 3 years-2.00%
3 months+3.98% 5 years+1.10%
1 year+1.42% Since inception+0.94%
Data through --

Peer Comparisonvs. Miscellaneous region

 AMDAXCategory
Performance 5-yr return+1.10%+3.00%
Expense ratio4.34%1.77%
Risk 5 year sharpe ratio0.27--
Net assets$8.7M$299.5M
Average market cap$6.2B$2.6B
Average P/E18.913.5
Portfolio turnover5%5%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyAMIDEX
Fund manager & tenureGadi Beer / 14 Years
Minimal initial investment$500.00
Minimum IRA investment$500.00

Holdings

International stock64.35%
U.S. stock35.17%
Cash0.47%
Fixed income0.02%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 27.12%
Healthcare 24.31%
Telecommunication 13.32%
Consumer goods 4.11%
Hardware 2.63%
Top 10 Holdings
Portfolio weighting
CHKP Check Point Software Technologies Ltd9.69%
MBBYF Mobileye BV7.83%
TEVA Teva Pharmaceutical7.28%
PRGO Perrigo Company PLC6.38%
DOX Amdocs Ltd5.17%
-- 4.42%
-- 3.92%
-- 3.80%
-- 3.61%
TARO Taro Pharmaceutical Industries Ltd3.16%